Mayo Clinic lines up AI innovation partner to help fight COVID-19

A supplier of remote patient monitoring technology is working with the Mayo Clinic to speed up diagnosis of COVID-19 and predict its course in stricken patients using AI.

In announcing the collaboration, the vendor, Boston-based Current Health, says it will combine its existing patient database with algorithms developed by Mayo Clinic for not only fighting COVID but also personalizing care for other patients with complex medical conditions.

The Current Health database already contains anonymized datasets on vital signs and physiological sensors from hundreds of patients infected with COVID-19, the company says.

The partnership will allow the two teams to “scale data analytics, add to Mayo Clinic’s major advancements in accelerating COVID-19 detection and diagnosis, and further efforts to understand and treat this disease,” Current adds.

The leader of Mayo’s COVID investigative team, Jordan Miller, PhD, calls combating the present pandemic “our number one priority.”

As part of the partnership, Mayo Clinic will become an investor in Current Health, according to the announcement.

Dave Pearson

Dave P. has worked in journalism, marketing and public relations for more than 30 years, frequently concentrating on hospitals, healthcare technology and Catholic communications. He has also specialized in fundraising communications, ghostwriting for CEOs of local, national and global charities, nonprofits and foundations.

Around the web

The final list also included diabetes drugs sold by Boehringer Ingelheim and Merck. The first round of drug price negotiations reduced the Medicare prices for 10 popular drugs by up to 79%. 

HHS has thought through the ways AI can and should become an integral part of healthcare, human services and public health. Last Friday—possibly just days ahead of seating a new secretary—the agency released a detailed plan for getting there from here.

Philips is recalling the software associated with its Mobile Cardiac Outpatient Telemetry devices after certain high-risk ECG events were never routed to trained cardiology technicians as intended. The issue, which lasted for two years, has been linked to more than 100 injuries.